Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Transcend |
Description | Developing the next generation of psychoactive compounds for neuropsychiatry focused on patient Transcend Therapeutics is a biotechnology company discovering, developing and delivering the next generation of psychoactive compounds focused on patient access to create a world where people no longer suffer with neuropsychiatric |
Keywords | N/A |
WebSite | transcendtherapeutics.com |
Host IP | 75.2.70.75 |
Location | United States |
Site | Rank |
US$4,179,307
Last updated: 2023-05-17 18:42:18
transcendtherapeutics.com has Semrush global rank of 2,532,550. transcendtherapeutics.com has an estimated worth of US$ 4,179,307, based on its estimated Ads revenue. transcendtherapeutics.com receives approximately 482,228 unique visitors each day. Its web server is located in United States, with IP address 75.2.70.75. According to SiteAdvisor, transcendtherapeutics.com is safe to visit. |
Purchase/Sale Value | US$4,179,307 |
Daily Ads Revenue | US$3,858 |
Monthly Ads Revenue | US$115,735 |
Yearly Ads Revenue | US$1,388,816 |
Daily Unique Visitors | 32,149 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
transcendtherapeutics.com. 3600 | A | transcendtherapeutics.com. 3600 | IP: 75.2.70.75 |
transcendtherapeutics.com. 3600 | A | transcendtherapeutics.com. 3600 | IP: 99.83.190.102 |
transcendtherapeutics.com. 21600 IN | NS | NS Record: ns-cloud-a3.googledomains.com. | |
transcendtherapeutics.com. 21600 IN | NS | NS Record: ns-cloud-a2.googledomains.com. | |
transcendtherapeutics.com. 21600 IN | NS | NS Record: ns-cloud-a4.googledomains.com. | |
transcendtherapeutics.com. 21600 IN | NS | NS Record: ns-cloud-a1.googledomains.com. | |
transcendtherapeutics.com. 3600 | MX | transcendtherapeutics.com. 3600 | MX Record: 5 alt2.aspmx.l.google.com. |
transcendtherapeutics.com. 3600 | MX | transcendtherapeutics.com. 3600 | MX Record: 10 alt3.aspmx.l.google.com. |
transcendtherapeutics.com. 3600 | MX | transcendtherapeutics.com. 3600 | MX Record: 10 alt4.aspmx.l.google.com. |
transcendtherapeutics.com. 3600 | MX | transcendtherapeutics.com. 3600 | MX Record: 5 alt1.aspmx.l.google.com. |
transcendtherapeutics.com. 3600 | MX | transcendtherapeutics.com. 3600 | MX Record: 1 aspmx.l.google.com. |
transcendtherapeutics.com. 3600 | TXT | transcendtherapeutics.com. 3600 | TXT Record: v=spf1 include:_spf.google.com ~all |
About us TEAM Publications News Careers Transcend Therapeutics announces Series A funding round of $40 million Developing the next generation of psychoactive compounds for neuropsychiatry focused on patient access. WORK WITH US Contact us to learn more THE PROBLEM Neuropsychiatric illness is the largest cause of disability worldwide... 1B People worldwide suffering from mental illnesses 3 X Increase in incidence of major depression since 2019 20 % Lifetime prevalence of major depression in US adults $ 2.5 T Mental illness costs the world economy $2.5T yearly, which is expected to grow to $6T by 2030 ...and there is a lack of investment and innovation for developing new treatments. Sources: World Health Organization (2020); Substance Abuse and Mental Health Services Administration (2016); Panchel et al. (2021); The Lancet (2020); NIH (2021); Bell (2020) We’re a biotechnology company discovering, developing, and delivering the next generation of psychoactive compounds focused on |
HTTP/1.1 301 Moved Permanently Server: openresty Date: Wed, 13 Apr 2022 09:31:11 GMT Content-Type: text/html Content-Length: 166 Connection: keep-alive Location: https://transcendtherapeutics.com/ HTTP/2 301 server: openresty date: Wed, 13 Apr 2022 09:31:12 GMT content-type: text/html content-length: 166 location: https://www.transcendtherapeutics.com/ HTTP/2 200 server: openresty date: Wed, 13 Apr 2022 09:31:12 GMT content-type: text/html content-length: 16912 via: 1.1 varnish, 1.1 varnish accept-ranges: bytes age: 0 x-served-by: cache-iad-kcgs7200069-IAD, cache-dub4339-DUB x-cache: MISS, MISS x-cache-hits: 0, 0 x-timer: S1649842273.522316,VS0,VE330 vary: x-wf-forwarded-proto, Accept-Encoding x-cluster-name: eu-west-1-prod-eks-15 |
Domain Name: TRANSCENDTHERAPEUTICS.COM Registry Domain ID: 2310077720_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.google.com Registrar URL: http://domains.google.com Updated Date: 2021-01-06T02:25:46Z Creation Date: 2018-09-14T18:19:36Z Registry Expiry Date: 2023-09-14T18:19:36Z Registrar: Google LLC Registrar IANA ID: 895 Registrar Abuse Contact Email: registrar-abuse@google.com Registrar Abuse Contact Phone: +1.8772376466 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS-CLOUD-A1.GOOGLEDOMAINS.COM Name Server: NS-CLOUD-A2.GOOGLEDOMAINS.COM Name Server: NS-CLOUD-A3.GOOGLEDOMAINS.COM Name Server: NS-CLOUD-A4.GOOGLEDOMAINS.COM DNSSEC: unsigned >>> Last update of whois database: 2022-04-13T09:56:30Z <<< |